0001203311-16-000133.txt : 20160822 0001203311-16-000133.hdr.sgml : 20160822 20160822213823 ACCESSION NUMBER: 0001203311-16-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160822 FILED AS OF DATE: 20160822 DATE AS OF CHANGE: 20160822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cline Darren S CENTRAL INDEX KEY: 0001633639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 161846316 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-08-22 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001633639 Cline Darren S 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 EVP, Commercial Common Stock 2016-08-22 4 S 0 1774.0 46.5907 D 40973 D Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Includes 562 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on July 29, 2016. /s/ Darren Cline 2016-08-22